Login   / DE |   EN
Grünenthal Group

Area of Interest: Out-Licensing

What we are looking for:

Out-Licencing

Our products may present an opportunity for you – through a licensing agreement in your market, a co-marketing arrangement, or another chance to collaborate.

Our tamper-resistant formulation technology INTAC® represents an innovative approach to address the issues of abuse of prescription drugs. This novel technology platform for immediate release (IR) and modified release (MR) formulations can also be used for various non-opioid drugs prone to abuse. For more information, please see www.intac.grunenthal.com  

Read our recent press releases on Grünenthal Out-Licencing projects

More about Areas of Interest

Europe

In European markets, we are focusing on marketed prescription products for the retail and / or hospital business as well as medical devices – in pain or in indications that target our existing customer groups.  Continue...

North America

One focus of our company relevent to North America is to work with further licensing partners for our innovative abuse deterrent formulation technology, INTAC®.  Continue...

Latin America

For Latin American markets, our focus lies with products in late stage clinical development, ready to be filed, or marketed.  Continue...

Research and Development

As a worldwide leader in pain, we are well placed to create innovative solutions for patients with various pain diseases. We are looking for partnerships for Rx products as well as medical devices. Continue...

Contract Manufacturing

As full-service CMO with more than 40 years of experience, we can offer tailored solutions to meet your needs – including the manufacture of controlled drugs. Continue...

Grünenthal ©